ASH 2015 highlights by Prof. Michael Hallek
Overview of new combinaton therapies in acute myeloid leukemia (AML)
Naval G. Daver
Preliminary results of a phase Ib study combining ABT-199 and obinutuzumab in CLL
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Panel discussion on mantle cell lymphoma
Constantine Tam et al.